AzTrials
AzTrials

Kidney Stones, Urolithiasis, HypocitraturiaAPULNCT04073719

Apple Cider Vinegar for the Prevention of Urinary Lithiasis (APUL)

A study testing Apple Cider Vinegar and Other Beverage in people with Kidney Stones, Urolithiasis, Hypocitraturia, run by United States Naval Medical Center, San Diego.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to assess whether certain beverages can increase urinary citrate levels in healthy individuals with no history of kidney disease. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
What is being tested?
Apple Cider Vinegar and Other Beverage
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
No sites listed yet
Study dates
1 Sep 2019to 31 May 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Male and female volunteers 18-65 years old

Who cannot join

  • History of peptic ulcer disease or gastroparesis
  • Pregnant females
  • History of chronic kidney disease
  • History of urolithiasis
  • Currently taking medications that interfere with urinary electrolyte excretion (thiazide and loop diuretics)javascript:document.
  • History of Diabetes

Trial locations and contacts

No sites are listed yet.

Christine M Herfroth, MD contact

6195327227

christine.m.herforth.mil@mail.mil

Jesse E Resovsky, BS contact

6195327226

jreso001@gmail.com

About this study

The purpose of this study is to assess whether certain beverages can increase urinary citrate levels in healthy individuals with no history of kidney disease.

Read the detailed description

Higher urinary citrate levels have been shown to decrease one's risk of developing kidney stones. The study will compare apple cider vinegar, coconut water, diet citric soda and lemonade and determine which is superior at raising citrate levels. Research participants will consume two of the four drinks, each for 7 day periods, according to a prescribed regimen. Throughout the course of the study, participants will periodically provide blood draws for metabolic panels, as well as 24-hour urine samples to measure citrate levels. There will be 12 study arms, accounting for the permutations of two drinks for each patients out of four possibilities. 3 participants per arm is the goal, for a total of 36, but the recruitment aim is 50 participants, to account for dropout and noncompliance.

Being tested
Apple Cider Vinegar, Other Beverage
Keywords
Kidney Stones, Urolithiasis, Hypocitraturia, Apple Cider Vinegar
Medical subject headings
Kidney Calculi, Urolithiasis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Apple Cider VinegarDietary supplement

    Will drinking apple cider vinegar increase urinary citrate levels to a greater degree than other beverages and which beverages produce the most significant effects compared against one another.

  • Other BeverageDietary supplement

    To what degree do other high citrate beverages impact urinary citrate output.

Study groups in NCT04073719
Study groupRoleWhat they receive
Apple Cider Vinegar + Coconut WaterExperimentalPatients will drink apple cider vinegar for 7 days. After a washout period of 2 weeks, patients will then drink coconut water for 7 days.
Receives: Dietary Supplement: Apple Cider Vinegar
Apple Cider Vinegar + Citric SodaExperimentalPatients will drink apple cider vinegar for 7 days. After a washout period of 2 weeks, patients will then drink citric soda for 7 days.
Receives: Dietary Supplement: Apple Cider Vinegar
Apple Cider Vinegar + LemonadeExperimentalPatients will drink apple cider vinegar for 7 days. After a washout period of 2 weeks, patients will then drink lemonade for 7 days.
Receives: Dietary Supplement: Apple Cider Vinegar
Coconut Water + Apple Cider VinegarExperimentalPatients will drink coconut water for 7 days. After a washout period of 2 weeks, patients will then drink apple cider vinegar for 7 days.
Receives: Dietary Supplement: Apple Cider Vinegar
Coconut Water + Citric SodaExperimentalPatients will drink coconut water for 7 days. After a washout period of 2 weeks, patients will then drink citric soda for 7 days.
Receives: Dietary Supplement: Other Beverage
Coconut Water + LemonadeExperimentalPatients will drink coconut water for 7 days. After a washout period of 2 weeks, patients will then drink lemonade for 7 days.
Receives: Dietary Supplement: Other Beverage
Citric Soda + Apple Cider VinegarExperimentalPatients will drink citric soda for 7 days. After a washout period of 2 weeks, patients will then drink apple cider vinegar for 7 days.
Receives: Dietary Supplement: Apple Cider Vinegar; Dietary Supplement: Other Beverage
Citric Soda + Coconut WaterExperimentalPatients will drink citric soda for 7 days. After a washout period of 2 weeks, patients will then drink coconut water for 7 days.
Receives: Dietary Supplement: Other Beverage
Citric Soda + LemonadeExperimentalPatients will drink citric soda for 7 days. After a washout period of 2 weeks, patients will then drink lemonade for 7 days.
Receives: Dietary Supplement: Other Beverage
Lemonade + Apple Cider VinegarExperimentalPatients will drink lemonade for 7 days. After a washout period of 2 weeks, patients will then drink apple cider vinegar for 7 days.
Receives: Dietary Supplement: Apple Cider Vinegar
Lemonade + Coconut WaterExperimentalPatients will drink lemonade for 7 days. After a washout period of 2 weeks, patients will then drink coconut water for 7 days.
Receives: Dietary Supplement: Other Beverage
Lemonade + Citric SodaExperimentalPatients will drink lemonade for 7 days. After a washout period of 2 weeks, patients will then drink citric soda for 7 days.
Receives: Dietary Supplement: Other Beverage

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Apple Cider Vinegar Urinary Citrate Increase

    Determine the change in urinary citrate levels due to the addition of apple cider vinegar to the diet

    Measured: 1 week

Secondary outcomes (3)
  1. Apple Cider Vinegar and urinary pH

    Determine the effect of apple cider vinegar on urinary pH

    Measured: 1 week

  2. Apple Cider Vinegar Against Other Beverages

    Compare the effect of apple cider vinegar on urinary citrate with that of known citrate-rich beverages (lemonade, citrus based soda, coconut water)

    Measured: 4 weeks

  3. Palatability Evaluation

    Compare the palatability of apple cider vinegar and other known citrate-rich beverages (lemonade, citrus based soda, coconut water). Patients will keep daily log whwere they can free write any side effects (from palatability perspective and otherwise). At the end of the study a 2 question survery (Likert scale format) will be filled in which participants will answer the liklihood of their willingness to consume the beverage daily for the prevention of kidney stones.

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Aug 2019
  2. Study start1 Sep 2019 (estimated)
  3. Primary completion31 May 2021 (estimated)
  4. Study completion31 May 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Model description
Prospective randomized sample of 36 patients, in a nested cross over design.
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04073719
Sponsor's protocol ID
NMCSD.2019.0026
Acronym
APUL
Status last verified
Aug 2019
First submitted
28 Aug 2019
Last updated
30 Aug 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Scales CD Jr, Smith AC, Hanley JM, Saigal CS; Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012 Jul;62(1):160-5. doi: 10.1016/j.eururo.2012.03.052. Epub 2012 Mar 31.

    PubMed 22498635
  • Pearle MS, Calhoun EA, Curhan GC; Urologic Diseases of America Project. Urologic diseases in America project: urolithiasis. J Urol. 2005 Mar;173(3):848-57. doi: 10.1097/01.ju.0000152082.14384.d7.

    PubMed 15711292
  • Johnson CM, Wilson DM, O'Fallon WM, Malek RS, Kurland LT. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int. 1979 Nov;16(5):624-31. doi: 10.1038/ki.1979.173.

    PubMed 548606
  • Bansal AD, Hui J, Goldfarb DS. Asymptomatic nephrolithiasis detected by ultrasound. Clin J Am Soc Nephrol. 2009 Mar;4(3):680-4. doi: 10.2215/CJN.05181008. Epub 2009 Mar 4.

    PubMed 19261817
  • Bhatti UH, Duffy AJ, Roberts KE, Shariff AH. Nephrolithiasis after bariatric surgery: A review of pathophysiologic mechanisms and procedural risk. Int J Surg. 2016 Dec;36(Pt D):618-623. doi: 10.1016/j.ijsu.2016.11.025. Epub 2016 Nov 12.

    PubMed 27847289
  • Maalouf NM, Tondapu P, Guth ES, Livingston EH, Sakhaee K. Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery. J Urol. 2010 Mar;183(3):1026-30. doi: 10.1016/j.juro.2009.11.022. Epub 2010 Jan 21.

    PubMed 20096421
  • Sakhaee K. Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens. 2008 May;17(3):304-9. doi: 10.1097/MNH.0b013e3282f8b34d.

    PubMed 18408483
  • Sakhaee K, Maalouf NM, Kumar R, Pasch A, Moe OW. Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int. 2011 Feb;79(4):393-403. doi: 10.1038/ki.2010.473. Epub 2010 Dec 1.

    PubMed 21124301
  • Sakhaee K. Recent advances in the pathophysiology of nephrolithiasis. Kidney Int. 2009 Mar;75(6):585-95. doi: 10.1038/ki.2008.626. Epub 2008 Dec 10.

    PubMed 19078968
  • Worcester EM, Coe FL. Clinical practice. Calcium kidney stones. N Engl J Med. 2010 Sep 2;363(10):954-63. doi: 10.1056/NEJMcp1001011. No abstract available.

    PubMed 20818905
  • Curhan GC, Taylor EN. 24-h uric acid excretion and the risk of kidney stones. Kidney Int. 2008 Feb;73(4):489-96. doi: 10.1038/sj.ki.5002708. Epub 2007 Dec 5.

    PubMed 18059457
  • Nicar MJ, Skurla C, Sakhaee K, Pak CY. Low urinary citrate excretion in nephrolithiasis. Urology. 1983 Jan;21(1):8-14. doi: 10.1016/0090-4295(83)90113-9.

    PubMed 6823713
  • Rudman D, Kutner MH, Redd SC 2nd, Waters WC 4th, Gerron GG, Bleier J. Hypocitraturia in calcium nephrolithiasis. J Clin Endocrinol Metab. 1982 Dec;55(6):1052-7. doi: 10.1210/jcem-55-6-1052.

    PubMed 7130336
  • Pak CY, Poindexter JR, Adams-Huet B, Pearle MS. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med. 2003 Jul;115(1):26-32. doi: 10.1016/s0002-9343(03)00201-8.

    PubMed 12867231
  • Pak CY; New Collective Author. Citrate and renal calculi: an update. Miner Electrolyte Metab. 1994;20(6):371-7.

    PubMed 7783699

Questions about this trial

What is this clinical trial studying?

A study testing Apple Cider Vinegar and Other Beverage in people with Kidney Stones, Urolithiasis, Hypocitraturia, run by United States Naval Medical Center, San Diego.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Christine M Herfroth, MD (6195327227, christine.m.herforth.mil@mail.mil), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Apple Cider Vinegar Urinary Citrate Increase (time frame: 1 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04073719, which also lists 43 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Aug 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in